Skip to main content
Virbac logo

Virbac — Investor Relations & Filings

Ticker · FR000 ISIN · FR0000031577 LEI · 969500QQ1X5XHG649644 PA Manufacturing
Open in API
Filings indexed 975 across all filing types
Latest filing 2019-09-16 Interim / Quarterly Rep…
Country FR France
Listing PA FR000

About Virbac

https://corporate.virbac.com/home.html

Virbac is an independent pharmaceutical company exclusively dedicated to animal health. Founded in 1968 by a veterinarian, the company provides veterinarians, farmers, and pet owners with a comprehensive range of products and services. Its portfolio of innovative solutions covers the majority of animal species and diseases, with a focus on both companion and farm animals. Key product areas include vaccines, dermatology, parasite control, dental care, nutrition, and diagnostics. Through its international R&D network, Virbac develops solutions to prevent, diagnose, and treat animal pathologies, contributing to animal welfare and supporting sustainable farming.

Recent filings

Filing Released Lang Actions
Virbac : résultat opérationnel courant du premier semestre 2019 en forte croissance
Interim / Quarterly Report Classification · 95% confidence The document provides a detailed summary of financial results for the first half of 2019, including consolidated figures, income statements, balance sheet items, and management commentary on performance, outlook, and financial ratios. While it mentions that the full accounts are available on the corporate website and includes a link to a PDF attachment, the text itself contains substantive financial data and analysis, qualifying it as an Interim/Quarterly Report (IR) rather than just a publication announcement. H1 2019
2019-09-16 French
Virbac: operating profit on the rise in the first half of 2019
Earnings Release Classification · 99% confidence The document is a public release dated September 16, 2019, presenting consolidated financial data for the first half of 2019 (H1 2019), including revenue, operating profit, and net profit comparisons with H1 2018. It provides detailed financial metrics, commentary on business performance, outlook for 2019, and notes that the accounts were audited and the statutory auditor's report is being issued. This content structure—a detailed summary of interim financial results and management discussion—is characteristic of an Interim/Quarterly Report (IR). Although it contains an announcement for an Analysts' Presentation, the core of the document is the H1 financial performance review, making 'IR' the most appropriate classification over 'ER' (which is usually just the initial highlights) or 'RPA' (as this is the report itself, not just an announcement of its publication). H1 2019
2019-09-16 English
Virbac : résultat opérationnel courant du premier semestre 2019 en forte croissance
Interim / Quarterly Report Classification · 95% confidence The document is a financial press release from Virbac detailing their first-half 2019 financial results. It includes consolidated financial tables (revenue, operating income, net income, debt) and a detailed management discussion and analysis of the performance. While it mentions an upcoming analyst presentation, the document itself contains the substantive financial data and analysis for the interim period, qualifying it as an Interim/Quarterly Report (IR) rather than a mere announcement or presentation. H1 2019
2019-09-16 French
Virbac : Rapport financier semestriel 2019
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Rapport financier semestriel' (Semi-annual financial report) for the period ending June 30, 2019. It contains detailed financial statements, analysis of revenue by activity and region, and a description of the financial situation. It is a comprehensive report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H1 2019
2019-09-16 French
Virbac : Half-yearly financial report 2019
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Half-yearly financial report' for the period ending June 30, 2019. It contains detailed financial statements, revenue analysis by segment and region, and a review of the financial situation. It is a comprehensive interim report rather than a mere announcement or summary, fitting the definition of an Interim/Quarterly Report (IR). H1 2019
2019-09-16 English
Virbac : Déclaration d'actions et de droits de vote 08/2019
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a 'Declaration d'actions et de droits de vote' (Declaration of shares and voting rights) filed in accordance with Article 223-16 of the AMF General Regulation. It provides the total number of shares and voting rights as of a specific date (August 31, 2019). This type of disclosure is a standard regulatory requirement for listed companies to report changes in their capital structure and voting rights, which falls under the 'Declaration of Voting Results & Voting Rights Announcements' category.
2019-09-06 French

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.